strontium/headache

Lyen an sove nan clipboard la

Chwazi kalite sòt

5 rezilta yo

Strontium ranelate for preventing and treating postmenopausal osteoporosis.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Strontium ranelate is a new anti-osteoporosis therapy therefore, its benefits and harms need to be known. OBJECTIVE To determine the efficacy and safety of strontium ranelate for the treatment and prevention of postmenopausal osteoporosis. METHODS We searched MEDLINE (1996 to March 2005),

Alopecia associated with strontium ranelate use in a 62-year-old woman.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Strontium ranelate is an effective drug that was developed for treating osteoporosis. Here, we report the case of a 62-year-old woman who developed headache and diffuse scalp hair loss 1 week after receiving strontium ranelate treatment for osteoporosis. The treatment was subsequently stopped

Strontium ranelate--data on vertebral and nonvertebral fracture efficacy and safety: mechanism of action.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Strontium ranelate is a novel therapy for the treatment of postmenopausal osteoporosis with actions to reduce bone resorption and increase bone formation. In vitro, strontium ranelate has anabolic and antiresorptive activity, increasing collagen and non-collagen protein synthesis, enhancing

Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The pharmacological management of disease should involve consideration of the balance between the beneficial effects of treatment on outcome and the probability of adverse effects. The aim of this review is to explore the risk of adverse drug reactions and drug-drug interactions with treatments for

Adverse drug reactions to osteoporosis treatments.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Treatments for postmenopausal osteoporosis are generally safe, but are linked to some rare serious adverse drug reactions, for which causality is not always certain. The bisphosphonates are associated with gastrointestinal effects, acute phase reactions, and musculoskeletal pain, and, more rarely,

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye